Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»New Study Shows Third Dose of Pfizer-BioNTech COVID Vaccine May Protect Against Omicron
    Health

    New Study Shows Third Dose of Pfizer-BioNTech COVID Vaccine May Protect Against Omicron

    By American Association for the Advancement of Science (AAAS)January 18, 20224 Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    COVID Vaccine Effective Response Success
    Three doses of the Pfizer-BioNTech COVID-19 vaccine have been shown to effectively counter the Omicron variant by boosting neutralizing antibody levels to those comparable to the initial Wuhan virus strain after two doses.

    Research indicates a third dose of Pfizer’s COVID-19 vaccine significantly enhances protection against the Omicron variant, restoring antibody levels to a robust state.

    A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses could offer a sufficient level of protection from disease caused by the Omicron variant.

    The globally circulating SARS-CoV-2 Variant of Concern (VOC) Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may be compromised. Alexander Muik and colleagues tested Wuhan, Beta, Delta, or Omicron pseudoviruses with sera of 51 participants that received two or three doses of the mRNA-based COVID-19 vaccine BNT162b2.

    Impact of Multiple Vaccine Doses

    Following two doses, sera had more than 22-fold reduced neutralizing titers against Omicron compared to Wuhan pseudovirus. One month after the third vaccine dose, Omicron-neutralizing titers were increased 23-fold compared to two doses, with titers similar to Wuhan-neutralizing titers after two doses.

    The data suggest “a third dose of BNT162b2 augments antibody-based immunity against Omicron, in line with previous observations that a third vaccination broadens humoral immune responses against VOCs,” say the authors.

    Conclusion and Future Research Directions

    “Further clinical trial and real-world data will soon emerge to address the effectiveness of a third dose with BNT162b2 against COVID-19 mediated by Omicron,” they conclude.

    Reference: “Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera” by Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, Maren Bacher, Julia Mühl, Jonas Reinholz, Orkun Ozhelvaci, Nina Beckmann, Ramón de la Caridad Güimil Garcia, Asaf Poran, Svetlana Shpyro, Andrew Finlayson, Hui Cai, Qi Yang, Kena A. Swanson, Özlem Türeci and Uğur Şahin, 18 January 2022, Science.
    DOI: 10.1126/science.abn7591

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    American Association for the Advancement of Science COVID-19 Immunology Infectious Diseases Popular Public Health Vaccine Virology
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Cross-Protective COVID Immunity: One Coronavirus Vaccine Can Provide Broad Immunity Against Other Coronaviruses

    Structural Changes Identified in COVID Alpha and Beta Variants – Suggests Need for Updated Vaccine Booster

    Experts Warn: Vaccines Alone May Not Be Enough to End COVID-19 Pandemic

    Researchers Identify Key Biomarker That Predicts Who Will Have Severe COVID-19

    Highly Effective Coronavirus Antibodies Identified – Basis for Passive COVID-19 Vaccination

    Small Neutralizing Antibody Identified That May Prevent COVID-19 Infection

    Research Shows Exposure to Common Cold Coronaviruses Can Teach the Immune System to Recognize SARS-CoV-2

    Common Molecular Feature of Antibodies That Neutralize SARS-CoV-2 Discovered, Boosting COVID-19 Vaccine Prospects

    FDA Approved Drug May Help Calm Cytokine Storm in COVID-19

    4 Comments

    1. Shamus on January 18, 2022 3:24 pm

      And… it may not.

      Reply
    2. Carlq on January 20, 2022 12:54 pm

      I had 2 Pfizer immunizations and the Booster end of September. Still got Omricon but grateful for the very mild symptoms. I will quarantine 10 days, not 5-7. The problem is my Doctor says I may still test positive up to 90 days out! Antigens remain in your system even if not sick.

      Reply
    3. Gail drake on February 7, 2022 4:41 pm

      So the first two don’t buy the third does
      Yeah I got swamp land to sell

      Reply
    4. Robert R. Frank on March 5, 2025 3:54 pm

      So, how does the. Average person person choose which vaccine they should have? And, who’s advice do I accept?

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    This Copper Drug Clears Alzheimer’s Brain Toxins and Boosts Memory

    Adults Over 65 Lost Massive Amounts of Weight With Ozempic

    How Flocking Birds “Defy” One of Physics’ Most Fundamental Laws

    Physicists Create a New Kind of Schrödinger’s Cat State From Exotic Quantum Building Blocks

    Your Diet Could Be Missing the Key Ingredient for Heart Protection

    Researchers Warn Widely Prescribed Blood Pressure Drugs Could Be Harming Diabetic Kidneys

    James Webb Spots Something Strange Between Day and Night on an Alien Planet

    How Ancient People Moved a 6-Ton Stone 700 Kilometers to Stonehenge

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Just Found Something Weird Inside Moss
    • Scientists Just Repeated a Nobel Prize-Winning Experiment in a Creature Older Than Jellyfish
    • Scientists Finally Uncover Why Solid-State Batteries Short-Circuit
    • Scientists Discover the “Achilles’ Heel” of Two of the World’s Deadliest Diarrhea Bacteria
    • Why Older Adults Need To Pay Closer Attention to Vitamin B12
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.